Examkin

Question

Difficulty: HardGeneral Internal Medicine

An internal medicine rapid response team is activated for a 6868-year-old hospitalized male who developed profound lower extremity weakness and lethargy. The patient was admitted two days ago for a diabetic foot infection and is receiving intravenous piperacillin-tazobactam. His home medications, including lisinopril and spironolactone for heart failure with reduced ejection fraction, were continued on admission. Over the past 1212 hours, his urine output has dropped significantly to 150150 mL. Vital signs demonstrate a heart rate of 4242/min and a blood pressure of 98/6098/60 mmHg. A point-of-care basic metabolic panel reveals a serum potassium of 7.87.8 mEq/L and a serum creatinine of 3.23.2 mg/dL (baseline 1.41.4 mg/dL). A stat 1212-lead electrocardiogram demonstrates widened QRS complexes, absent P waves, and peaked T waves.

Arrange the following management steps in the most appropriate chronological sequence for this patient's acute presentation, from the most immediate intervention to subsequent actions.

  1. 1Administer intravenous calcium gluconate to antagonize myocardial membrane excitability.
  2. 2Infuse intravenous regular insulin with 50% dextrose to drive potassium into the intracellular space.
  3. 3Administer an enteral potassium-binding resin to facilitate gastrointestinal potassium excretion.
  4. 4Discontinue the patient's lisinopril and spironolactone to prevent ongoing potassium retention.
  5. 5Prepare for urgent hemodialysis if medical management is inadequate and oliguria persists.

Answer

The correct sequence is: 1) Administer intravenous calcium gluconate, 2) Infuse intravenous regular insulin with dextrose, 3) Administer an enteral potassium-binding resin, 4) Discontinue lisinopril and spironolactone, 5) Prepare for urgent hemodialysis.
The algorithm for severe hyperkalemia dictates that life-saving membrane stabilization with intravenous calcium (onset 1-3 minutes) must occur first. This is immediately followed by agents that shift potassium into cells (insulin/dextrose, onset 15-30 minutes) to buy time. Next, definitive elimination therapies like gastrointestinal binders (onset 2-6 hours) are given, alongside stopping offending agents (ACE inhibitors/MRAs) to prevent recurrence. Finally, if conservative measures fail or the patient remains anuric, hemodialysis serves as the ultimate rescue therapy.

Step-by-Step Solution

1
Recognize severe, symptomatic hyperkalemia with cardiotoxicity.
Identification of a life-threatening emergency requiring immediate membrane stabilization.
The patient's potassium is critically high (7.87.8 mEq/L) with corresponding bradycardia and widened QRS complexes, indicating imminent risk of cardiac arrest.
2
Prioritize rapid-acting pharmacological interventions based on time to onset.
Intravenous calcium gluconate is administered first (onset 1-3 minutes), followed by insulin and dextrose (onset 15-30 minutes).
Myocardial stabilization must occur before shifting agents take effect to prevent fatal arrhythmias during the interim.
3
Implement measures for total body potassium reduction and secondary prevention.
Gastrointestinal binders are administered (onset in hours), and offending medications are halted.
Intracellular shifting is only temporary. True elimination of potassium is required for definitive resolution.
4
Establish a rescue plan for refractory hyperkalemia.
Preparation for hemodialysis is initiated.
The patient has severe acute kidney injury with oliguria, making pharmacological elimination unreliable.

Key Concept

The algorithmic pharmacological management of severe hyperkalemia follows a strict physiological hierarchy based on time-to-onset: membrane stabilization, followed by intracellular shifting, and finally, total body elimination.
Estimated Time:1m 30s
Rate this question

Topics

General Internal Medicine

More questions from this topic